Complete Filing Data
Delixy Holdings Ltd reported Stockholders Equity of $1.35 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Delixy Holdings Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenues | $314.9M | $289.2M | $319.8M |
| Other Nonoperating Income | $5.0K | $2.0K | $12.0K |
| Operating Income Loss | $706.0K | $1.1M | $217.0K |
| Net Income Loss | $1.0M | $1.2M | $253.0K |
| Interest Expense Operating | $178.0K | $23.0K | $12.0K |
| Income Taxes Paid | $219.0K | $25.0K | $23.0K |
| Income Tax Expense Benefit | $98.0K | $225.0K | $69.0K |
| Gross Profit | $4.3M | $4.1M | $2.4M |
| General And Administrative Expense | $3.6M | $3.0M | $2.2M |
| Cost Of Revenue | $310.6M | $285.0M | $317.4M |
| Comprehensive Income Net Of Tax | $1.0M | $1.2M | $253.0K |
| Amortization Of Intangible Assets | $57.0K | $43.0K | $45.0K |
| Restructuring Charges | -$50.0K | -$45.0K | |
| Nonoperating Income Expense | $420.0K | $255.0K | $105.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $1.1M | $1.4M | $322.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Stockholders Equity | $1.4M | $1.8M | $11.9M | $11.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.3M | $8.2M | $6.1M | $8.7M |
| Taxes Payable Current | $127.0K | $246.0K | $46.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$4.9M | $2.2M | -$2.7M | |
| Retained Earnings Accumulated Deficit | $612.0K | $1.1M | ||
| Prepaid Expense And Other Assets Current | $575.0K | $35.0K | ||
| Operating Lease Right Of Use Asset | $62.0K | $49.0K | ||
| Operating Lease Liability Noncurrent | $18.0K | $7.0K | ||
| Operating Lease Liability Current | $42.0K | $42.0K | ||
| Liabilities Noncurrent | $5.0M | $7.0K | ||
| Liabilities Current | $17.3M | $8.6M | ||
| Liabilities And Stockholders Equity | $23.7M | $10.4M | ||
| Liabilities | $22.3M | $8.6M | ||
| Dividends Common Stock | $1.5M | $11.2M | ||
| Derivative Assets Current | $685.0K | $607.0K | ||
| Cash And Cash Equivalents At Carrying Value | $3.3M | $8.2M | ||
| Assets Noncurrent | $1.4M | $840.0K | ||
| Assets Current | $22.3M | $9.6M | ||
| Assets | $23.7M | $10.4M | ||
| Additional Paid In Capital Common Stock | $695.0K | $695.0K | ||
| Accrued Liabilities Current | $50.0K | $75.0K | ||
| Accounts Receivable Net Current | $17.5M | $713.0K | ||
| Repayments Of Related Party Debt | $175.0K | |||
| Property Plant And Equipment Net | $791.0K | |||
| Long Term Loans Payable | $5.0M | |||
| Gain Loss On Sale Of Property Plant Equipment | $177.0K | |||
| Dividends Payable Current | $8.2M | |||
| Dividend Payable | $5.0M | |||
| Deferred Costs | $1.3M | |||
| Accounts Payable Current | $17.1M | |||
| Repayments Of Bank Debt | $458.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $612.0K | $4.1M | -$4.9M |
| Net Cash Provided By Used In Investing Activities | $552.0K | -$188.0K | $2.7M |
| Net Cash Provided By Used In Financing Activities | -$6.1M | -$1.7M | -$458.0K |
| Increase Decrease In Other Receivables | $540.0K | -$24.0K | $50.0K |
| Increase Decrease In Other Accrued Liabilities | -$25.0K | -$44.0K | -$32.3M |
| Increase Decrease In Operating Lease Liability | -$62.0K | -$47.0K | -$49.0K |
| Increase Decrease In Accrued Income Taxes Payable | -$119.0K | $200.0K | $46.0K |
| Increase Decrease In Accounts Receivable | $16.8M | -$2.7M | -$27.1M |
| Proceeds From Amount Due From Shareholder | $327.0K | $81.0K | |
| Payments Of Dividends | $4.7M | $1.5M | |
| Increase Decrease In Interest Payable Net | -$20.0K | -$10.0K | |
| Proceeds From Sale Of Property Plant And Equipment | $957.0K | ||
| Payments Of Stock Issuance Costs | $1.3M | ||
| Increase Decrease In Accounts Payable | $17.1M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 15.0M | 15.0M | 15.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 15.0M | 15.0M | 15.0M |
| Earnings Per Share Diluted | $0.07 | $0.08 | $0.02 |
| Earnings Per Share Basic | $0.07 | $0.08 | $0.02 |
| Common Stock Shares Issued | 15.0M | 15.0M | |
| Common Stock Shares Authorized | 100.00B | 100.00B | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Investment Income Interest | $183.0K | $250.0K | $42.0K |
| Interest Paid Net | $3.0K | $23.0K | $12.0K |
| Foreign Currency Transaction Gain Loss Before Tax | $5.0K | $3.0K | $6.0K |
| Derivative Financial Instruments | $78.0K | $107.0K | -$2.7M |
| Depreciation | $11.0K | $24.0K | $24.0K |
| Other Reserve | $46.0K | $46.0K | |
| Unrealized Gain Loss On Derivatives | $21.0K | -$36.0K | |
| Loan From Shareholder | $5.0M | ||
| Amount Due From Shareholder | $152.0K |
Most recent annual filing with the SEC: May 13, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.